Cohance Lifesciences Limited
COHANCE
주식 순위
#6395
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
주가
$5.05
마지막 동기화: 2026-10-19
시가총액
$1.93B
변동 (1일)
-1.44%
변동 (1년)
-57.38%
국가
IN
거래 Cohance Lifesciences Limited (COHANCE)
카테고리
Healthcare
Cohance Lifesciences Limited (COHANCE)의 P/B 비율
October 2026 기준 P/B 비율 TTM: 22.54
Cohance Lifesciences Limited의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 22.54입니다. 2024년 말 기준 P/B 비율은 8.31였습니다.
Cohance Lifesciences Limited의 P/B 비율 기록 (2019 ~ 2026)
매년 말 P/B 비율
| 연도 | P/B 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
유사 기업 또는 경쟁사의 P/B 비율
| 회사 | P/B 비율 | P/B 비율 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
